Green Cross Health provides access to professional healthcare with over 300 Unichem and Life Pharmacies covering almost every New Zealand community, as well as 65 medical centres caring for over 400,000 enrolled patients.
The AFR said that private equity interest in New Zealand’s healthcare system was on the boil.
Early this year, US private equity giant TPG bought New Zealand’s biggest privately owned primary healthcare group, Tamaki Health, for around $500 million.
“Now, another buyout firm is seeking to stitch up a deal for one of Tamaki’s rivals,” the AFR said.
The paper said Deloitte Corporate Finance is advising Green Cross, which has a market cap of $178m.
The company is headed up chief executive Rachael Newfield.
Its shares last traded at $1.23, having gained 67.5% over the last 12 months.
Jamie Gray is an Auckland-based journalist, covering the financial markets, the primary sector and energy. He joined the Herald in 2011.
Stay ahead with the latest market moves, corporate updates, and economic insights by subscribing to our Business newsletter – your essential weekly round-up of all the business news you need.